Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience (Q58051878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Murielle Roussel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Loic Campion

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

X Leleu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Marit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H Jardel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Dib

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

O Decaux

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Lamy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Tiab

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

P Cony-Makhoul

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Banos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Lepeu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

F Lifermann

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Macro

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

B Kolb

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Hulin

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

D Caillot

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Traulle

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Mathiot

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

B Royer

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

29 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

158-159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.176

8 February 2020

exact match

0 references

cites work

International staging system for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

Bortezomib is an efficient agent in plasma cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

Managing plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hé

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficacy and safety of bortezomib in patients with plasma cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.176

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2011.176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21799511%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference